WASHINGTON, Jan. 21, 2026 /PRNewswire/ — The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to supportWASHINGTON, Jan. 21, 2026 /PRNewswire/ — The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support

DIA Launches ASCENT Platform and LIFT Biotech & Startup Program to Accelerate Emerging Innovation

WASHINGTON, Jan. 21, 2026 /PRNewswire/ — The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support early-stage biotechnology drug development innovation, along with its inaugural initiative, the LIFT (Linking Innovation, Funding, and Translation) Series. Together, ASCENT and LIFT create a structured, multi-stage pathway to educate, prepare, and connect emerging biotech and startup companies with investors, regulators, pharma leaders, and development organizations across the full product lifecycle.

DIA announces ASCENT and LIFT Series to advance early-stage biotech innovation and collaboration.

Built to address persistent barriers facing early-stage innovators, such as limited investor access, fragmented access to expertise, and unclear regulatory pathways, and steep execution gaps, ASCENT extends DIA’s role as a trusted, multi-stakeholder convener to the earliest phases of innovation. Through curated education, mentorship, regulatory insight, and global exposure, the platform aims to strengthen the life sciences innovation pipeline worldwide.

The DIA LIFT Series unfolds across three integrated program offerings in 2026. Phase I launches with a Virtual Masterclass Series beginning in February 2026, featuring expert-led sessions with case studies focused on fund-raising, drug development including the role of AI, regulatory strategy, clinical development and financial modeling.

Phase II brings LIFT Series to DIA Europe 2026 in Rotterdam, Netherlands (March 24–26, 2026), with dedicated LIFT Programming for Biotech & Startups embedded within a globally attended meeting of more than 2,500 professionals. Programming includes expert coaching, live pitch competitions, regulator and investor roundtables, and curated networking opportunities.

Phase III culminates at the DIA 2026 Global Annual Meeting  in Philadelphia, Pennsylvania (June 14–18, 2026), featuring expanded LIFT Series Biotech & Startup programming, a Startup Row, and two targeted pitch events focused on drug and therapy development and techbio innovation, all within a 4,000+ attendee global forum.

“Our mission has always been to convene the global life sciences community to improve health worldwide,” said Marwan Fathallah, CEO of DIA. “With ASCENT and the LIFT Series Program, we are extending that mission earlier in the innovation journey providing emerging companies with the insight, connections, and visibility needed to advance promising science and strengthen the entire ecosystem.”

Registration for the LIFT Virtual Masterclass Series is now open. Details for Annual Meeting registrations and pitch competitions is available with pitch applications opening soon.

To learn more, visit: https://connect.diaglobal.org/dia-ascent-1

About DIA

DIA is a leading global non-profit life science membership association that drives collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries.

Learn more at DIAglobal.org.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dia-launches-ascent-platform-and-lift-biotech–startup-program-to-accelerate-emerging-innovation-302665447.html

SOURCE Drug Information Association

Market Opportunity
Startup Logo
Startup Price(STARTUP)
$0.0001593
$0.0001593$0.0001593
-0.68%
USD
Startup (STARTUP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Polygon Tops RWA Rankings With $1.1B in Tokenized Assets

Polygon Tops RWA Rankings With $1.1B in Tokenized Assets

The post Polygon Tops RWA Rankings With $1.1B in Tokenized Assets appeared on BitcoinEthereumNews.com. Key Notes A new report from Dune and RWA.xyz highlights Polygon’s role in the growing RWA sector. Polygon PoS currently holds $1.13 billion in RWA Total Value Locked (TVL) across 269 assets. The network holds a 62% market share of tokenized global bonds, driven by European money market funds. The Polygon POL $0.25 24h volatility: 1.4% Market cap: $2.64 B Vol. 24h: $106.17 M network is securing a significant position in the rapidly growing tokenization space, now holding over $1.13 billion in total value locked (TVL) from Real World Assets (RWAs). This development comes as the network continues to evolve, recently deploying its major “Rio” upgrade on the Amoy testnet to enhance future scaling capabilities. This information comes from a new joint report on the state of the RWA market published on Sept. 17 by blockchain analytics firm Dune and data platform RWA.xyz. The focus on RWAs is intensifying across the industry, coinciding with events like the ongoing Real-World Asset Summit in New York. Sandeep Nailwal, CEO of the Polygon Foundation, highlighted the findings via a post on X, noting that the TVL is spread across 269 assets and 2,900 holders on the Polygon PoS chain. The Dune and https://t.co/W6WSFlHoQF report on RWA is out and it shows that RWA is happening on Polygon. Here are a few highlights: – Leading in Global Bonds: Polygon holds 62% share of tokenized global bonds (driven by Spiko’s euro MMF and Cashlink euro issues) – Spiko U.S.… — Sandeep | CEO, Polygon Foundation (※,※) (@sandeepnailwal) September 17, 2025 Key Trends From the 2025 RWA Report The joint publication, titled “RWA REPORT 2025,” offers a comprehensive look into the tokenized asset landscape, which it states has grown 224% since the start of 2024. The report identifies several key trends driving this expansion. According to…
Share
BitcoinEthereumNews2025/09/18 00:40
QNT Technical Analysis Jan 21

QNT Technical Analysis Jan 21

The post QNT Technical Analysis Jan 21 appeared on BitcoinEthereumNews.com. QNT’s MACD histogram showing a positive trend and RSI stabilizing in the neutral zone
Share
BitcoinEthereumNews2026/01/21 23:54
SHIB Alert: First Three-Hour Death Cross Flashes on Chart in 2026, Is It Important?

SHIB Alert: First Three-Hour Death Cross Flashes on Chart in 2026, Is It Important?

The post SHIB Alert: First Three-Hour Death Cross Flashes on Chart in 2026, Is It Important? appeared on BitcoinEthereumNews.com. Shiba Inu is forming a death cross
Share
BitcoinEthereumNews2026/01/22 00:26